cystetic Medicines
PrivateLast Round
VC Round
Nov 1, 2020
Company Overview
cystetic Medicines is a clinical-stage biotechnology company pioneering the development of small molecule anion channel molecular prosthetics to restore pulmonary function in people with Cystic Fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
cystetic Medicines Comparables
Compare cystetic Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spirovant Sciences | 79% | |
| ReCode Therapeutics | 77% | |
| SpliSense | 77% | |
cystetic Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 1, 2020 |
cystetic Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | VC Round |
| Illinois Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2020
$25M round led by Deerfield Management
cystetic Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about cystetic Medicines's valuation, stock price, and market status.